News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
232,083 Results
Type
Article (5090)
Company Profile (24)
Press Release (226969)
Multimedia
Podcasts (2)
Webinars (4)
Section
Business (82245)
Career Advice (463)
Deals (15054)
Drug Delivery (8)
Drug Development (19075)
Employer Resources (30)
FDA (3682)
Job Trends (3909)
News (120178)
Policy (7512)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (293)
Accelerated approval (6)
Adcomms (4)
Allergies (14)
Alliances (14807)
ALS (38)
Alzheimer's disease (295)
Antibody-drug conjugate (ADC) (41)
Approvals (3782)
Artificial intelligence (83)
Autoimmune disease (27)
Automation (6)
Bankruptcy (97)
Best Places to Work (2865)
Biosimilars (32)
Biotechnology (23)
Bladder cancer (34)
Brain cancer (7)
Breast cancer (102)
Cancer (890)
Cardiovascular disease (61)
Career advice (395)
Career pathing (3)
CAR-T (64)
CDC (2)
Cell therapy (167)
Cervical cancer (5)
Clinical research (16690)
Collaboration (358)
Compensation (374)
Complete response letters (8)
COVID-19 (311)
CRISPR (13)
C-suite (342)
Cystic fibrosis (28)
Data (1332)
Denatured (1)
Depression (21)
Diabetes (79)
Diagnostics (2118)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (13)
Drug discovery (33)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (42759)
Editorial (5)
Employer branding (6)
Employer resources (32)
Events (39146)
Executive appointments (427)
FDA (4422)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (344)
Gene editing (24)
Generative AI (6)
Gene therapy (104)
GLP-1 (145)
Government (423)
Guidances (197)
Healthcare (5046)
HIV (11)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (39)
Immuno-oncology (8)
Indications (16)
Infectious disease (337)
Inflammatory bowel disease (36)
Inflation Reduction Act (3)
Influenza (6)
Intellectual property (32)
Interviews (53)
IPO (7880)
IRA (3)
Job creations (1122)
Job search strategy (361)
JPM (4)
Kidney cancer (10)
Labor market (10)
Layoffs (106)
Leadership (5)
Legal (2337)
Liver cancer (21)
Longevity (2)
Lung cancer (96)
Lymphoma (70)
Machine learning (3)
Management (10)
Manufacturing (142)
MASH (50)
Medical device (3919)
Medtech (3929)
Mergers & acquisitions (7584)
Metabolic disorders (219)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (54)
Neuropsychiatric disorders (12)
Neuroscience (541)
NextGen: Class of 2026 (1674)
Non-profit (731)
Now hiring (5)
Obesity (88)
Opinion (32)
Ovarian cancer (26)
Pain (26)
Pancreatic cancer (38)
Parkinson's disease (50)
Partnered (6)
Patents (53)
Patient recruitment (98)
Peanut (6)
People (25225)
Pharmaceutical (7)
Pharmacy benefit managers (2)
Phase 1 (4995)
Phase 2 (7228)
Phase 3 (5789)
Pipeline (1987)
Policy (17)
Postmarket research (625)
Preclinical (1946)
Press Release (66)
Prostate cancer (57)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (180)
Real estate (1886)
Recruiting (8)
Regulatory (5542)
Reports (17)
Research institute (309)
Resumes & cover letters (69)
Rett syndrome (19)
RNA editing (1)
RSV (2)
Schizophrenia (49)
Series A (53)
Series B (57)
Sickle cell disease (10)
Special edition (1)
Spinal muscular atrophy (33)
Sponsored (5)
Startups (1017)
Stomach cancer (1)
Supply chain (13)
Tariffs (7)
The Weekly (1)
Vaccines (80)
Venture capital (9)
Weight loss (30)
Women's health (6)
Date
Today (33)
Last 7 days (167)
Last 30 days (581)
Last 365 days (8927)
2026 (866)
2025 (9036)
2024 (11030)
2023 (13193)
2022 (18658)
2021 (19678)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (186)
Alabama (19)
Alaska (2)
Arizona (74)
Arkansas (1)
Asia (11786)
Australia (1691)
California (3554)
Canada (1144)
China (170)
Colorado (145)
Connecticut (163)
Delaware (71)
Europe (25500)
Florida (543)
Georgia (67)
Idaho (24)
Illinois (162)
India (16)
Indiana (107)
Iowa (9)
Japan (166)
Kansas (36)
Kentucky (17)
Louisiana (8)
Maine (51)
Maryland (352)
Massachusetts (2824)
Michigan (104)
Minnesota (202)
Mississippi (1)
Missouri (32)
Montana (17)
Nebraska (12)
Nevada (46)
New Hampshire (16)
New Jersey (1027)
New Mexico (5)
New York (817)
North Carolina (482)
North Dakota (4)
Northern California (1865)
Ohio (116)
Oklahoma (5)
Oregon (6)
Pennsylvania (599)
Puerto Rico (2)
Rhode Island (19)
South America (279)
South Carolina (17)
Southern California (1306)
Tennessee (62)
Texas (486)
United States (12395)
Utah (111)
Virginia (85)
Washington D.C. (17)
Washington State (297)
West Virginia (2)
Wisconsin (58)
Wyoming (1)
232,083 Results for "altpep corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AltPep Corporation Presents New Preclinical Data at CTAD 2025 Demonstrating SOBIN-AD, its Custom-Designed Peptide for Alzheimer’s Disease, Improves Behavior in Both Symptomatic and Asymptomatic Disease
December 2, 2025
·
4 min read
Press Releases
AltPep Corporation Appoints Alan Colowick, M.D., M.P.H. to Board of Directors
February 13, 2025
·
3 min read
Business
AltPep Appoints Soon Hyouk Lee to Newly Created Position of Chief Business Officer
AltPep Corporation today announced that Soon Hyouk Lee has assumed the position of Chief Business Officer of AltPep.
December 13, 2023
·
2 min read
BioForest
AltPep Study Published in Nature Journal, Scientific Reports, Further Affirms Potential of Blood Test to Detect Alzheimer’s Disease
AltPep Corporation announced that the peer-reviewed Nature journal Scientific Reports has published new results from the Company’s evaluation of its novel SOBA-AD blood test, aimed at detecting Alzheimer’s disease.
April 5, 2024
·
4 min read
Business
AltPep Further Strengthens Advisory Board with Appointment of Steven E. Kahn, M.B., Ch.B.
AltPep Corporation announced the appointment of Steven E. Kahn, M.B., Ch.B. to its Advisory Board.
November 15, 2023
·
3 min read
BioForest
AltPep Corporation Announces Close of $53 Million Series B Financing to Advance Its Novel Therapeutics for both Alzheimer’s and Parkinson’s Diseases into the Clinic
AltPep Corporation today announced the completion of a $52.9 million Series B financing round.
June 22, 2023
·
3 min read
Business
AltPep Strengthens Advisory Board with Three Leading Experts in Alzheimer’s Disease and Neurodegenerative Disorders
AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, today announced the appointment of three new Advisory Board members: Paul Aisen, M.D., Sam Gandy, M.D., Ph.D., and Charlie Glabe, Ph.D.
February 9, 2023
·
3 min read
Business
AltPep Appoints Nancy Hill to Newly Created Position of Chief Product Officer
AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, announced that accomplished executive Nancy Hill has assumed the newly created role of Chief Product Officer.
February 24, 2022
·
2 min read
BioForest
AltPep Receives FDA Breakthrough Device Designation for SOBA-AD, A Simple Blood Test for the Detection of Alzheimer’s Disease
AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, today announced the U.S. Food and Drug Administration (FDA) granted the company Breakthrough Device designation for its SOBA-AD diagnostic in development for Alzheimer’s disease (AD).
March 1, 2022
·
3 min read
Press Releases
Santhera Appoints Stifel as Corporate Finance Advisor
February 10, 2026
·
2 min read
1 of 23,209
Next
